Your browser doesn't support javascript.
loading
High IL-7 levels in the bone marrow microenvironment mediate imatinib resistance and predict disease progression in chronic myeloid leukemia.
Zhang, Xiaoyan; Tu, Huaijun; Yang, Yazhi; Wan, Qian; Fang, Lijun; Wu, Qiong; Li, Jian.
Afiliação
  • Zhang X; The Key Laboratory of Hematology of Jiangxi Province, The Department of Hematology, The Second Affiliated Hospital of Nanchang University, 1 Minde Road, Nanchang, 330006, Jiangxi, P.R. China.
  • Tu H; Basic Medical school, Nanchang University, Nanchang, 330006, Jiangxi, P.R. China.
  • Yang Y; Graduate School of Medicine, Nanchang University, Nanchang, 330006, Jiangxi, P.R. China.
  • Wan Q; The Department of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, P.R. China.
  • Fang L; The Key Laboratory of Hematology of Jiangxi Province, The Department of Hematology, The Second Affiliated Hospital of Nanchang University, 1 Minde Road, Nanchang, 330006, Jiangxi, P.R. China.
  • Wu Q; Graduate School of Medicine, Nanchang University, Nanchang, 330006, Jiangxi, P.R. China.
  • Li J; The Key Laboratory of Hematology of Jiangxi Province, The Department of Hematology, The Second Affiliated Hospital of Nanchang University, 1 Minde Road, Nanchang, 330006, Jiangxi, P.R. China.
Int J Hematol ; 104(3): 358-67, 2016 Sep.
Article em En | MEDLINE | ID: mdl-27272942
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Leucemia Mielogênica Crônica BCR-ABL Positiva / Interleucina-7 / Progressão da Doença / Resistencia a Medicamentos Antineoplásicos / Mesilato de Imatinib Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Leucemia Mielogênica Crônica BCR-ABL Positiva / Interleucina-7 / Progressão da Doença / Resistencia a Medicamentos Antineoplásicos / Mesilato de Imatinib Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article